Pfizer Board Meeting May 12 for FY26 Results

Pfizer's Board will meet on May 12, 2026 to approve Q4 and FY26 financial results and consider dividend recommendation.
The trading window for insiders is closed from March 31 until 48 hours after results are made public on May 12.
This disclosure is made pursuant to SEBI Listing Regulations to inform exchanges and depository participants.